Navigation Links
Convoy Therapeutics Announces the Relaunch of Their Interactive Website
Date:1/16/2013

Las Vegas (PRWEB) January 16, 2013

Convoy Therapeutics, a subsidiary of ACTUS Biotechnologies, is proud to announce the relaunching of their website. The revised website includes new information regarding the company's platform technology and development programs.

The interactive website provides a user-friendly platform for interested parties to gather information regarding Convoy Therapeutics’ innovative platform technology and its various uses in enabling the penetration of macromolecules and retention of small molecules in the skin for a wide variety of cosmetic and therapeutic uses.
“The revamped website offers comprehensive information regarding Convoy’s ground-breaking technology and how it can be applied in a variety of uses in cosmetic and therapeutic applications,” says Dr. Robert Davis, Chief Business Officer of Convoy Therapeutics. “Perhaps more importantly, it shows the incredible healing opportunities possible when combining other therapies with our skin-penetrating technologies.” Convoy Therapeutics’ main objective is to provide a platform for effective and efficient drug, cosmeceutical, or active delivery into the skin. “The website demonstrates the difference between the previous systems of skin delivery and Convoy’s technology,” adds Dr. Davis.

The newly designed website includes diagrams, videos, and slide presentations that visually demonstrate the Convoy technology penetrating the outer layers of the skin, delivering therapeutic macromolecules. Treatment areas include: dermatology, immunology, vaccinations, and cancer. The website also contains information regarding the company's development pipeline including: CY-102, a reformulated Cyclosporine for topical use in treating psoriasis currently in late stage development, and HA-102PH, a topical cosmetic preparation of hyaluronic acid for enhanced skin tone and hydration also in the later development stages.

The
'/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2

Related biology technology :

1. Cell Therapeutics, Inc. Reports Results of Annual Meeting of Shareholders
2. Nile Therapeutics Reports 2011 Third Quarter Financial Results
3. Nile Therapeutics Announces Top-Line Results in Clinical Trial Evaluating the Subcutaneous Infusion of Cenderitide, Meets Primary Endpoint
4. Fate Therapeutics Strengthens Its iPSC Platform
5. Amsterdam Molecular Therapeutics Provides Business Update for the Third Quarter 2011
6. MarketsandMarkets: Global Prostate Cancer Therapeutics Market worth $6,457 Million by 2020
7. MarketsandMarkets: Leukemia Therapeutics Market Worth $11.3 Billion by 2020
8. Roche Signs Agreement with PTC Therapeutics to Advance Treatment for Spinal Muscular Atrophy (SMA)
9. Echo Therapeutics Announces Positive Results of Clinical Trial of its Symphony® Transdermal Continuous Glucose Monitoring (tCGM) System in Patients With Type 1 and Type 2 Diabetes
10. Aratana Therapeutics Completes $15 Million Series B Financing
11. MarketsandMarkets: Acute Lymphocytic Leukemia Therapeutics Market worth $3.88 Billion by 2020
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... , Jan. 22. 2015  Varian Medical Systems (NYSE: ... has been honored for its commitment to sustainability with inclusion ... Varian is the highest ranked healthcare equipment company among the ... during the World Economic Forum at Davos, Switzerland ...
(Date:1/22/2015)... N.J. , Jan. 22, 2015  Derma Sciences, ... regeneration company focused on advanced wound care, announces ... placental tissues, have been added to the Premier, ... increases the opportunity for the AMNIOEXCEL® and AMNIOMATRIX® ...
(Date:12/24/2014)... , Dec. 24, 2014  United Therapeutics Corporation (NASDAQ: ... MDT ) has submitted a pre-market approval ... for the use of Medtronic,s SynchroMed ® II ... for use with United Therapeutics, Remodulin ® (treprostinil) ...
(Date:12/24/2014)... , Dec. 24, 2014  Vermillion, Inc. (Nasdaq:   ... disease, announced today that the Company closed its ... Investment Management, Jack W. Schuler , Birchview ... were $10.5 million, before offering expenses.  The proceeds ...
Breaking Biology Technology:Varian Honored Among World's 100 Most Sustainable Corporations 2Derma Sciences Expands Access of its AMNIOTIC TISSUE Product Line with New Premier, Inc. Agreement 2Derma Sciences Expands Access of its AMNIOTIC TISSUE Product Line with New Premier, Inc. Agreement 3Derma Sciences Expands Access of its AMNIOTIC TISSUE Product Line with New Premier, Inc. Agreement 4Derma Sciences Expands Access of its AMNIOTIC TISSUE Product Line with New Premier, Inc. Agreement 5United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 2United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 3United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 4Vermillion Announces Closing of Equity Financing 2Vermillion Announces Closing of Equity Financing 3
... ... strategic communications agency, announced today that it has been selected by Invida Group, the ... its corporate communications and public relations program. , ... Salem, MA (Vocus) February 8, 2010 -- LaVoie ...
... politicians, and has been recounted everywhere from tourist guidebooks to ... weapons on Iraqis just after World War I. ... historical record, says R. M. Douglas, a historian at Colgate ... of The Journal of Modern History , no such ...
... , Company Develops Research Models for Cardiovascular Disease ... Renova Life Inc. ( www.renovalife.com ), a company developing ... the Maryland Technology Enterprise Institute (Mtech) Technology Advancement Program (TAP) ... founded in February 2009 , moved into TAP this ...
Cached Biology Technology:Invida Selects LaVoie Group as Public Relations Agency of Record 2Invida Selects LaVoie Group as Public Relations Agency of Record 3Despite claims, UK did not gas Iraqis in the 1920s, new research finds 2Despite claims, UK did not gas Iraqis in the 1920s, new research finds 3Despite claims, UK did not gas Iraqis in the 1920s, new research finds 4Renova Life Inc. Joins Mtech Incubator 2Renova Life Inc. Joins Mtech Incubator 3
(Date:12/17/2014)... DUBLIN , Dec. 15, 2014 Research and Markets ... of the "Samsung Galaxy S5 - Home Button ... offering. http://photos.prnewswire.com/prnh/20130307/600769 ... the iPhone 5S, Samsung introduces for the first time ...
(Date:12/17/2014)... , Dec. 16, 2014  Automation is fundamentally transforming ... than at international borders. Over the past decade, ePassports, ... travelers to self process through border control via eGates ... number of airports, seaports, and land borders across the ...
(Date:12/11/2014)... ST. PAUL, Minn. , Dec. 10, 2014 ... wireless physiologic monitoring, has released a new series ... needs of preclinical toxicology researchers. M series, part ... help toxicologists collect the best possible physiologic data ...
Breaking Biology News(10 mins):Samsung Galaxy S5 - Home Button Synaptics Fingerprint Sensor Technology Analysis 2Automated Border Control (ABC) Transforms the Global Travel Experience With More Than 2500 ABC eGates and APC Kiosks Deployed In Airports, Seaports, and Land Borders Worldwide 2New telemetry implants expected to change how large animal toxicology studies are conducted 2
... all in the packaging. How nature wraps and tags genes ... from Harvard and the Massachusetts Institute of Technology (M.I.T.). They ... protein structure that surrounds the human genome. , Their findings ... switched on during development of the human body and in ...
... controversial technical barrier in stem cell biology, scientists at ... have crafted a recipe that allows researchers to grow ... "feeder" cells, long thought to be a source of ... new findings, appear today (Feb. 17) in the journal ...
... as,inevitable and obvious as “going gray,?yet scientists have ... usually unwelcome transformation.,In a report posted today on ... Dana-Farber Cancer Institute and Children’s Hospital,Boston say they ... while,investigating the origins of malignant melanoma, the potentially ...
Cached Biology News:Protein Packages Found To Activate Genes; May Be What Regulates Development And Disease 2Protein Packages Found To Activate Genes; May Be What Regulates Development And Disease 3Scientists rid stem cell culture of key animal cells 2Scientists rid stem cell culture of key animal cells 3Scientists discover the cellular roots of graying hair 2Scientists discover the cellular roots of graying hair 3
Mouse polyclonal antibody raised against a partial recombinant CSRP3. NCBI Entrez Gene ID = 8048...
Mouse monoclonal antibody raised against a partial recombinant EOMES. NCBI Entrez Gene ID = EOMES...
...
... 2-D Sample Preparation for Membrane Proteins ... 25 membrane,protein extracts for 2-D gel analysis ... Protein Extraction Kit , (contains ... with a packed cell weight of 10 ...
Biology Products: